Fig. 1From: Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trialDays from injury to death in placebo group patients randomised within 3 h of injury overall and by severity (GCS) and country income, excluding those with GCS 3 or bilateral unreactive pupilsBack to article page